Primary Article
Treatment Of Mania: Relationship Between Response to Verapamil and Changes in Plasma Calcium and Magnesium Levels
Abstract
ABSTRACT: Twelve patients meeting DSM-IIIR criteria for mania received verapamil over a 2-week period, with dosing up to 360 mg/day. Severity of mania was measured at baseline and weekly by use of the Young Mania Scale. Plasma calcium and magnesium determinations and an ECG were obtained at baseline and after 2 weeks of treatment. Mean improvement was from a baseline of 32.4 to 12.8, -60.5%. Decreased severity of mania correlated significantly with increased plasma calcium. This result may lend a method for monitoring successful treatment of mania with calcium channel inhibitors.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.